Pharmacy News

Is buprenorphine or methadone better for opioid use disorder in pregnancy?

Researchers of a new study published in the New England Journal of Medicine compared outcomes in pregnant patients with opioid use disorder based on whether they received opioid agonist therapy with buprenorphine as opposed to methadone.

FDA grants fast track approval for OTC nasal spray

FDA has reportedly put an OTC version of naloxone nasal spray (Narcan—Emergent BioSolutions) on the fast track to approval.

Recovering COVID patients seem to have elevated risk for newly diagnosed diabetes

A study in BMC Medicine found that people recovering from COVID-19 are at higher risk of being newly diagnosed with diabetes.

Shingles may increase risk for stroke, heart attack

A new study published in the Journal of the American Heart Association found that shingles, also known as herpes zoster, is associated with an almost 30% higher long-term risk of major cardiovascular events such as stroke or heart attack.

Study questions HDLs in predicting CVD risk

A new study in the Journal of the American College of Cardiology reported that HDL, typically regarded as “good cholesterol,” might not be as universally useful for determining people’s CVD risk as previously thought by researchers.